Clinical Trial Search

Primary: Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG — -18; 10; 11; -15 microvolts — p=>0.05

Primary: Voiding Efficiency — 87; 90 Percent voiding efficiency

Primary: Number of Participants Who Achieved Post-void Residual (PVR) of ≤150 ml Over 90 Days — 79 Participants

Primary: Number of Participants With a Change in Bladder Pressure — 0 participants

Primary: Number of Subjects With Complication After Treatment — 0 Participants

Primary: Baseline Sexual Satisfaction Between Matched Female and Male Partners — 4.2; 4.8 score on a scale — p=.16

Primary: Sensation as Indicated by the Volume of Water Filled (ml) at the Time of Patient Perception of First Sensation, First Urge to Void, Strong Urge to Void, and Full Bladder…

Primary: Incidence of Bladder Irritation Symptoms (e.g. Frequency, Urgency, Nocturia, Urine Leakage...) Associated With the RELIEF Stent. — 51.95 Units on a scale

Primary: A 50% Reduction in Pad Test Weight — 12; 4 Participants

Primary: Time to Successful Completion of Pelvic Ultrasound — 103.95; 92.82 minutes

Primary: Successful Trial Without Catheter Peri-procedurally — 29; 0 Participants

Primary: Number of Participants With Successful Sheath Placement — 37; 39 Participants

Primary: Mean Residual Urine Volume — 12.4; 9.4 mL

Primary: Change in Vaginal Microbiota — 2.75 change in percent relative abundance

Primary: Number of Participants Considered to Have Passed Their Voiding Trial — 30; 30 Participants

Primary: Change in the Relative Abundance of Lactobacillus — 0.143 proportion of total microbes

Primary: Total Catheter Related Pain — 1.25; 2.3 units on a scale

Primary: Urethral Opening Pressure (UOP) — 2.90411; -3.623431 cmH2O — p=0.07

Primary: Number of Participants With Urinary Tract Infection — 30; 22; 0; 0 Participants

Primary: Number of Subjects Catheterized Within the Six-week Post-operative Period Following Surgical Repair of Prolapse, Among Those Discharged Without a Urinary Catheter. — 2…

Primary: Voided Volume — 306 mL

Primary: Mean Stent Dwell Time — 17; 3.97 months

Primary: Visual Analog Scale (VAS) — 48; 20; 0; 28 score on a scale

Primary: Number of Participants With Treatment Failure Defined as Subsequent Treatment for Urinary Incontinence, Signs or Symptoms of Bothersome Urinary Incontinence — 39; 85…

Primary: Number of Participants Who Passed Bladder Trial — 25; 39 participants

Primary: Change in OAB Symptoms Post Pubovaginal Sling Operation — 63; 21; 4 participants — p=0.001

Primary: Urinary Tract Infection Rate — 24; 29 Participants — p=0.30

Primary: Number of Participants With Subjectively Bothersome Stress Incontinence — 129; 126 Participants

Primary: Change in Post-ureteroscopy Stent-induced Pain — 4.61; 3.11 units on a scale

Primary: Percent of Eligible Parents Screened (Feasibility) — 90.5 percentage of parents recruited